NVAX logo

Novavax (NVAX) Retained earnings

annual retained earnings:

-$5.01B-$187.50M(-3.89%)
December 31, 2024

Summary

  • As of today (May 21, 2025), NVAX annual retained earnings is -$5.01 billion, with the most recent change of -$187.50 million (-3.89%) on December 31, 2024.
  • During the last 3 years, NVAX annual retained earnings has fallen by -$1.39 billion (-38.43%).
  • NVAX annual retained earnings is now -18588.25% below its all-time high of -$26.80 million, reached on December 31, 1996.

Performance

NVAX Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXbalance sheet metrics

quarterly retained earnings:

-$4.49B+$518.65M(+10.36%)
March 31, 2025

Summary

  • As of today (May 21, 2025), NVAX quarterly retained earnings is -$4.49 billion, with the most recent change of +$518.65 million (+10.36%) on March 31, 2025.
  • Over the past year, NVAX quarterly retained earnings has increased by +$478.70 million (+9.63%).
  • NVAX quarterly retained earnings is now -19854.68% below its all-time high of -$22.50 million, reached on March 31, 1996.

Performance

NVAX quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

NVAX Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-3.9%+9.6%
3 y3 years-38.4%-31.5%
5 y5 years-249.8%-208.0%

NVAX Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-38.4%at low-31.5%+10.4%
5 y5-year-249.8%at low-208.0%+10.4%
alltimeall time<-9999.0%at low<-9999.0%+10.4%

NVAX Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$4.49B(-10.4%)
Dec 2024
-$5.01B(+3.9%)
-$5.01B(+1.6%)
Sep 2024
-
-$4.93B(+2.5%)
Jun 2024
-
-$4.81B(-3.3%)
Mar 2024
-
-$4.97B(+3.1%)
Dec 2023
-$4.82B(+12.7%)
-$4.82B(+3.8%)
Sep 2023
-
-$4.64B(+2.9%)
Jun 2023
-
-$4.51B(-1.3%)
Mar 2023
-
-$4.57B(+6.9%)
Dec 2022
-$4.28B(+18.2%)
-$4.28B(+4.5%)
Sep 2022
-
-$4.09B(+4.3%)
Jun 2022
-
-$3.93B(+15.0%)
Mar 2022
-
-$3.41B(-5.6%)
Dec 2021
-$3.62B(+93.0%)
-$3.62B(+30.5%)
Sep 2021
-
-$2.77B(+13.2%)
Jun 2021
-
-$2.45B(+16.8%)
Mar 2021
-
-$2.10B(+11.9%)
Dec 2020
-$1.87B(+30.9%)
-$1.87B(+10.5%)
Sep 2020
-
-$1.70B(+13.2%)
Jun 2020
-
-$1.50B(+2.9%)
Mar 2020
-
-$1.46B(+1.8%)
Dec 2019
-$1.43B(+10.2%)
-$1.43B(+2.3%)
Sep 2019
-
-$1.40B(+1.3%)
Jun 2019
-
-$1.38B(+3.0%)
Mar 2019
-
-$1.34B(+3.3%)
Dec 2018
-$1.30B(+16.6%)
-$1.30B(+3.9%)
Sep 2018
-
-$1.25B(+3.7%)
Jun 2018
-
-$1.21B(+3.8%)
Mar 2018
-
-$1.16B(+4.2%)
Dec 2017
-$1.11B(+19.8%)
-$1.11B(+4.8%)
Sep 2017
-
-$1.06B(+4.4%)
Jun 2017
-
-$1.02B(+4.6%)
Mar 2017
-
-$974.44M(+4.8%)
Dec 2016
-$930.00M(+43.1%)
-$930.00M(+6.5%)
Sep 2016
-
-$872.89M(+8.2%)
Jun 2016
-
-$806.63M(+10.9%)
Mar 2016
-
-$727.28M(+11.9%)
Dec 2015
-$650.03M(+31.8%)
-$650.03M(+13.8%)
Sep 2015
-
-$571.22M(+6.2%)
Jun 2015
-
-$538.10M(+4.0%)
Mar 2015
-
-$517.46M(+4.9%)
Dec 2014
-$493.09M(+20.2%)
-$493.09M(+6.8%)
Sep 2014
-
-$461.55M(+4.5%)
Jun 2014
-
-$441.82M(+4.2%)
Mar 2014
-
-$423.96M(+3.4%)
Dec 2013
-$410.15M(+14.5%)
-$410.15M(+3.5%)
Sep 2013
-
-$396.09M(+4.0%)
Jun 2013
-
-$380.79M(+3.4%)
Mar 2013
-
-$368.16M(+2.8%)
Dec 2012
-$358.16M(+8.6%)
-$358.16M(+2.3%)
Sep 2012
-
-$350.13M(+2.1%)
Jun 2012
-
-$342.91M(+1.8%)
Mar 2012
-
-$336.99M(+2.2%)
Dec 2011
-$329.66M(+6.2%)
-$329.66M(+1.1%)
Sep 2011
-
-$325.95M(+1.0%)
Jun 2011
-
-$322.74M(+1.6%)
Mar 2011
-
-$317.75M(+2.4%)
Dec 2010
-$310.29M
-$310.29M(+1.6%)
DateAnnualQuarterly
Sep 2010
-
-$305.34M(+3.5%)
Jun 2010
-
-$294.99M(+3.3%)
Mar 2010
-
-$285.56M(+4.0%)
Dec 2009
-$274.58M(+16.5%)
-$274.58M(+5.5%)
Sep 2009
-
-$260.19M(+3.0%)
Jun 2009
-
-$252.66M(+3.5%)
Mar 2009
-
-$244.13M(+3.5%)
Dec 2008
-$235.78M(+18.0%)
-$235.78M(+4.9%)
Sep 2008
-
-$224.70M(+3.6%)
Jun 2008
-
-$216.85M(+4.5%)
Mar 2008
-
-$207.48M(+3.9%)
Dec 2007
-$199.73M(+21.1%)
-$199.73M(+4.8%)
Sep 2007
-
-$190.51M(+4.9%)
Jun 2007
-
-$181.54M(+4.7%)
Mar 2007
-
-$173.35M(+5.1%)
Dec 2006
-$164.96M(+16.3%)
-$164.96M(+3.9%)
Sep 2006
-
-$158.81M(+3.3%)
Jun 2006
-
-$153.80M(+4.3%)
Mar 2006
-
-$147.39M(+3.9%)
Dec 2005
-$141.89M(+8.5%)
-$141.89M(-4.2%)
Sep 2005
-
-$148.05M(+1.9%)
Jun 2005
-
-$145.32M(+4.1%)
Mar 2005
-
-$139.61M(+6.8%)
Dec 2004
-$130.72M(+24.7%)
-$130.72M(+8.5%)
Sep 2004
-
-$120.43M(+2.3%)
Jun 2004
-
-$117.78M(+7.0%)
Mar 2004
-
-$110.06M(+5.0%)
Dec 2003
-$104.80M(+19.7%)
-$104.80M(+3.0%)
Sep 2003
-
-$101.72M(+3.4%)
Jun 2003
-
-$98.36M(+5.4%)
Mar 2003
-
-$93.33M(+6.6%)
Dec 2002
-$87.53M(+35.0%)
-$87.53M(+6.2%)
Sep 2002
-
-$82.38M(+8.9%)
Jun 2002
-
-$75.67M(+7.8%)
Mar 2002
-
-$70.17M(+8.2%)
Dec 2001
-$64.83M(+17.7%)
-$64.83M(+5.2%)
Sep 2001
-
-$61.64M(+4.2%)
Jun 2001
-
-$59.13M(+3.2%)
Mar 2001
-
-$57.32M(+4.1%)
Dec 2000
-$55.09M(+28.4%)
-$55.09M(+10.0%)
Sep 2000
-
-$50.10M(+6.9%)
Jun 2000
-
-$46.88M(+6.0%)
Mar 2000
-
-$44.24M(+3.1%)
Dec 1999
-$42.90M(+11.7%)
-$42.90M(+2.4%)
Sep 1999
-
-$41.90M(+4.2%)
Jun 1999
-
-$40.20M(+2.3%)
Mar 1999
-
-$39.30M(+2.3%)
Dec 1998
-$38.40M(+22.7%)
-$38.40M(+11.3%)
Sep 1998
-
-$34.50M(+3.6%)
Jun 1998
-
-$33.30M(+3.4%)
Mar 1998
-
-$32.20M(+2.9%)
Dec 1997
-$31.30M(+16.8%)
-$31.30M(+3.3%)
Sep 1997
-
-$30.30M(+4.1%)
Jun 1997
-
-$29.10M(+3.9%)
Mar 1997
-
-$28.00M(+4.5%)
Dec 1996
-$26.80M
-$26.80M(+7.6%)
Sep 1996
-
-$24.90M(+4.2%)
Jun 1996
-
-$23.90M(+6.2%)
Mar 1996
-
-$22.50M

FAQ

  • What is Novavax annual retained earnings?
  • What is the all time high annual retained earnings for Novavax?
  • What is Novavax annual retained earnings year-on-year change?
  • What is Novavax quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Novavax?
  • What is Novavax quarterly retained earnings year-on-year change?

What is Novavax annual retained earnings?

The current annual retained earnings of NVAX is -$5.01B

What is the all time high annual retained earnings for Novavax?

Novavax all-time high annual retained earnings is -$26.80M

What is Novavax annual retained earnings year-on-year change?

Over the past year, NVAX annual retained earnings has changed by -$187.50M (-3.89%)

What is Novavax quarterly retained earnings?

The current quarterly retained earnings of NVAX is -$4.49B

What is the all time high quarterly retained earnings for Novavax?

Novavax all-time high quarterly retained earnings is -$22.50M

What is Novavax quarterly retained earnings year-on-year change?

Over the past year, NVAX quarterly retained earnings has changed by +$478.70M (+9.63%)
On this page